Delivery Order SPE2DB20D2104-SPE2DB24FR37Z
Award Date
11/29/23
Potential Completion Date
11/30/23
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $29,606.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,323,524 units of Bupropion HCL XL 300 mg tablets, with a completion date of January 16, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $57,461.12 for the supply of Bupropion HCL XL 150 mg tablets to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022 through full and open competition, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $63,780.64, for the supply of 4564416340 - Bupropion HCL XL 300 MG Tablets in quantities of 500s. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,468.64 and is a Firm Fixed Price Delivery Order that runs through February 28, 2024. The contract was awarded on February 27, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,635,942 units of Bupropion HCL XL 150 mg tablets. The firm-fixed-price contract, valued at $15,644.19, has a completion date of February 13, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of medical products, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $51,618.39, is for the delivery of 4,564,448,914 units of Bupropion HCL XL 150 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of May 1, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various...
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The $12,760.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,044.34 for 4563775004 - Bupropion HCL XL 300 mg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD) that provides medical supplies and pharmaceuticals to the military and veterans' healthcare systems. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with a ceiling value of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,111.40, is for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a significant supplier of pharmaceutical products and...